27th ISMRM Annual Meeting • 11-16 May 2019 • Montréal, QC, Canada
Sunrise Session Multinuclear Imaging & Spectroscopy: Hyperpolarized 13C Use in Clinical Research & Trials |
|||||||||||||||
Multinuclear Imaging & Spectroscopy: Hyperpolarized 13C Use in Clinical Research & Trials
Sunrise Session ORGANIZERS: Yi-Fen Yen, Malgorzata Marjanska, Catherine Hines
Tuesday, 14 May 2019
Skill Level: Basic to Intermediate
Session Number: S-TU-05
Overview This is the second course of a four-part sunrise educational series on multi-nuclear imaging and spectroscopy. This course will discuss the current progress of hyperpolarized 13C imaging in clinical research and trials, beginning with technical implementation and demonstrating how trials and clinical studies are currently being performed for oncology and cardiovascular efforts. Target Audience MR scientists, MR technologists, clinicians, and scientists interested in performing hyperpolarized 13C studies clinically. Educational Objectives As a result of attending this course, participants should be able to: - Explain the current progress of hyperpolarized 13C imaging in clinical research for cardiac and cancer applications; and - Identify the requirements of implementing this technique clinically.
|
|||||||||||||||
Back to Program-at-a-Glance | Back to Top | |||||||||||||||
The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |